Cargando…
CRANAD-28: A Robust Fluorescent Compound for Visualization of Amyloid Beta Plaques
CRANAD-28, a difluoroboron curcumin analogue, has been demonstrated in earlier reports to successfully label amyloid beta (Aβ) plaques for imaging both ex vivo and in vivo. CRANAD-28’s imaging brightness, ability to penetrate the blood brain barrier, and low toxicity make the compound a potentially...
Autores principales: | Ran, Kathleen, Yang, Jing, Nair, Anil V., Zhu, Biyue, Ran, Chongzhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070309/ https://www.ncbi.nlm.nih.gov/pubmed/32079064 http://dx.doi.org/10.3390/molecules25040863 |
Ejemplares similares
-
In-vitro and in-vivo characterization of CRANAD-2 for multi-spectral optoacoustic tomography and fluorescence imaging of amyloid-beta deposits in Alzheimer mice
por: Ni, Ruiqing, et al.
Publicado: (2021) -
Differentiating Aβ40 and Aβ42 in amyloid plaques with a small molecule fluorescence probe
por: Yang, Jing, et al.
Publicado: (2020) -
Turn-on chemiluminescence probes and dual-amplification of signal for detection of amyloid beta species in vivo
por: Yang, Jing, et al.
Publicado: (2020) -
Degradation of amyloid beta species by multi-copper oxidases
por: Yang, Jing, et al.
Publicado: (2023) -
The Application of
Bio-orthogonality for In Vivo Animal
Imaging
por: Yang, Jun, et al.
Publicado: (2023)